Cargando…

PI3Kβ Inhibitor TGX221 Selectively Inhibits Renal Cell Carcinoma Cells with Both VHL and SETD2 mutations and Links Multiple Pathways

We aimed to exploit novel compounds with high selectivity to clear cell renal cell carcinoma (ccRCC) with common mutations. Using the GDSC databases, we searched for compounds with high selectivity for ccRCC with VHL and/or SETD2 mutations. Clinical impact and gene interactions were analysed using T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Chenchen, Sun, Yang, Ding, Guanxiong, Wu, Zhong, Jiang, Haowen, Wang, Lujia, Ding, Qiang, Wen, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396071/ https://www.ncbi.nlm.nih.gov/pubmed/25853938 http://dx.doi.org/10.1038/srep09465

Ejemplares similares

TGX-221 inhibits proliferation and induces apoptosis in human glioblastoma cells
por: Yang, Xue, et al.
Publicado: (2017)

Topical Application of the PI3Kβ-Selective Small Molecule Inhibitor TGX-221 Is an Effective Treatment Option for Experimental Epidermolysis Bullosa Acquisita
por: Zillikens, Hannah, et al.
Publicado: (2021)

Predictive Value of Clinicopathological Markers for the Metachronous Bladder Cancer and Prognosis of Upper Tract Urothelial Carcinoma
por: Feng, Chenchen, et al.
Publicado: (2014)

Association Study of Reported Significant Loci at 5q35.3, 7p14.3, 13q14.1 and 16p12.3 with Urolithiasis in Chinese Han Ethnicity
por: Wang, Lujia, et al.
Publicado: (2017)

SETD2 deficiency promotes renal fibrosis through the TGF‐β/Smad signalling pathway in the absence of VHL
por: Liu, Changwei, et al.
Publicado: (2023)

Editorial: In vitro toxicogenomics (TGx) in hazard and risk assessment
por: Beal, Marc A., et al.
Publicado: (2023)

SETD2 loss sensitizes cells to PI3Kβ and AKT inhibition
por: Terzo, Esteban A., et al.
Publicado: (2019)

Lipocalin 2 over-expression facilitates progress of castration-resistant prostate cancer via improving androgen receptor transcriptional activity
por: Ding, Guanxiong, et al.
Publicado: (2016)

Correction: SETD2 loss sensitizes cells to PI3Kβ and AKT inhibition
por: Terzo, Esteban A., et al.
Publicado: (2019)

Determination of the consequences of VHL mutations on VHL transcripts in renal cell carcinoma
por: TAYLOR, CLAIRE, et al.
Publicado: (2012)

Tumor Wide Horizontal Invasion Predicts Local Recurrence for Scrotal Extramammary Paget’s Disease
por: Wang, Lujia, et al.
Publicado: (2017)

pVHL Mediates K63-Linked Ubiquitination of nCLU
por: Xue, Jing, et al.
Publicado: (2012)

CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma
por: McRonald, Fiona E, et al.
Publicado: (2009)

Combination of Rapamycin, CI-1040, and 17-AAG Inhibits Metastatic Capacity of Prostate Cancer via Slug Inhibition
por: Ding, Guanxiong, et al.
Publicado: (2013)

TGx-DDI, a Transcriptomic Biomarker for Genotoxicity Hazard Assessment of Pharmaceuticals and Environmental Chemicals
por: Li, Heng-Hong, et al.
Publicado: (2019)

SETD1A promotes the proliferation and glycolysis of nasopharyngeal carcinoma cells by activating the PI3K/Akt pathway
por: Huang, Jianyi, et al.
Publicado: (2022)

The efficacy and safety of oncolytic viruses in the treatment of intermediate to advanced solid tumors: a systematic review and meta-analysis
por: Gao, Peng, et al.
Publicado: (2021)

Knockdown of tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta (YWHAZ) enhances tumorigenesis both in vivo and in vitro in bladder cancer
por: Liu, Shenghua, et al.
Publicado: (2018)

Overexpression of HSD17B4 exerts tumor suppressive function in adrenocortical carcinoma and is not associated with hormone excess
por: Ding, Guanxiong, et al.
Publicado: (2017)

Deciphering von Hippel-Lindau (VHL/Vhl)-Associated Pancreatic Manifestations by Inactivating Vhl in Specific Pancreatic Cell Populations
por: Shen, H.-C. Jennifer, et al.
Publicado: (2009)

PI3K/AKT/mTOR Dysregulation and Reprogramming Metabolic Pathways in Renal Cancer: Crosstalk with the VHL/HIF Axis
por: Badoiu, Silviu Constantin, et al.
Publicado: (2023)

VHL-deficiency leads to reductive stress in renal cells
por: Vellama, Hans, et al.
Publicado: (2023)

SETD2 deficiency accelerates sphingomyelin accumulation and promotes the development of renal cancer
por: Rao, Hanyu, et al.
Publicado: (2023)

Assessment of the performance of the TGx‐DDI biomarker to detect DNA damage‐inducing agents using quantitative RT‐PCR in TK6 cells
por: Cho, Eunnara, et al.
Publicado: (2018)

VHL-deficient renal cancer cells gain resistance to mitochondria-activating apoptosis inducers by activating AKT through the IGF1R-PI3K pathway
por: Yamaguchi, Ryuji, et al.
Publicado: (2016)

Flow cytometric micronucleus assay and TGx-DDI transcriptomic biomarker analysis of ten genotoxic and non-genotoxic chemicals in human HepaRG™ cells
por: Buick, Julie K., et al.
Publicado: (2020)

MicroRNA-221 Induces Cell Survival and Cisplatin Resistance through PI3K/Akt Pathway in Human Osteosarcoma
por: Zhao, Guangyi, et al.
Publicado: (2013)

Multi-Omics Profiling to Assess Signaling Changes upon VHL Restoration and Identify Putative VHL Substrates in Clear Cell Renal Cell Carcinoma Cell Lines
por: Wang, Xuechun, et al.
Publicado: (2022)

Von Hippel-Lindau (VHL) Inactivation in Sporadic Clear Cell Renal Cancer: Associations with Germline VHL Polymorphisms and Etiologic Risk Factors
por: Moore, Lee E., et al.
Publicado: (2011)

Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma
por: Hu, Junhui, et al.
Publicado: (2023)

Dual blocking of PI3K and mTOR signaling by DHW‐221, a novel benzimidazole derivative, exerts antitumor activity in human non‐small cell lung cancer
por: Qin, Xiaochun, et al.
Publicado: (2021)

Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells
por: TIAN, FENG, et al.
Publicado: (2015)

Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells
por: Tian, Feng, et al.
Publicado: (2023)

Application of the TGx‐28.65 transcriptomic biomarker to classify genotoxic and non‐genotoxic chemicals in human TK6 cells in the presence of rat liver S9
por: Yauk, Carole L., et al.
Publicado: (2016)

A Modern Genotoxicity Testing Paradigm: Integration of the High-Throughput CometChip® and the TGx-DDI Transcriptomic Biomarker in Human HepaRG™ Cell Cultures
por: Buick, Julie K., et al.
Publicado: (2021)

Decreased Expression of SETD2 Predicts Unfavorable Prognosis in Patients With Nonmetastatic Clear-Cell Renal Cell Carcinoma
por: Liu, Weisi, et al.
Publicado: (2015)

Estrogen preserves split renal function in a chronic complete unilateral ureteral obstruction animal model
por: MAO, SHANHUA, et al.
Publicado: (2014)

Histone methyltransferase SETD2: An epigenetic driver in clear cell renal cell carcinoma
por: Yu, Mengxue, et al.
Publicado: (2023)

Correction: MicroRNA-221 Induces Cell Survival and Cisplatin Resistance through PI3K/Akt Pathway in Human Osteosarcoma
por: Zhao, Guangyi, et al.
Publicado: (2013)

Characterization of VHL missense mutations in sporadic clear cell renal cell carcinoma: hotspots, affected binding domains, functional impact on pVHL and therapeutic relevance
por: Razafinjatovo, Caroline, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7c0ho2v18n4t3f50t65an20i7d